Gary Kiss resigned as director at BIOREGENX, INC..
“On April 4, 2025, Gary Kiss resigned from his position as director of BioRegenx, Inc., effective immediately.”
BIOREGENX, INC. — fact timeline
Source-grounded facts extracted from BIOREGENX, INC.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Gary Hennerberg resigned as director at BIOREGENX, INC..
“On April 7, 2025, Gary Hennerberg resigned from his position as director of BioRegenx, Inc., effective immediately.”
Robert Doran resigned as director at BIOREGENX, INC..
“On January 15, 2025, Robert Doran submitted his resignation from his position as director of BioRegenx, Inc., which shall be effective January 31, 2025.”
Richard Janney was appointed as Director at BIOREGENX, INC..
“On October 7, 2024, BioRegenx, Inc., a Nevada corporation (“BioRegenx”) appointed Richard Janney to serve as a member of its board of directors until his successor is elected and qualified, or until he resigns or is removed.”
BIOREGENX, INC.: Filed Certificate of Designation to ratify creation and issuance of 5,000,000 Series A preferred shares with voting rights of 2,500 votes per share (effective 2024-03-14).
“Effective March 14, 2024, the Registrant filed a Certificate of Designation (and subsequently, a Certificate of Correction) curing the 2013 creation of the Series A preferred shares and ratifying the issuances of 5,000,000 Series A preferred shares in 2013 which were retired pursuant to the terms of the merger. Each Series A preferred share has voting rights of 2,500 votes per Series A preferred share.”
BIOREGENX, INC.: Increased authorized common stock to 1.5 billion shares and changed company name to BioRegenx, Inc (effective 2024-03-08).
“Effective March 8, 2024, the Registrant filed an Amendment to the Articles of Incorporation which increased the authorized common stock to One Billion Five Hundred Thousand (1,500,000,000) common shares. Additionally, the name of the Registrant was changed to BioRegenx, Inc.”
BIOREGENX, INC. underwent a change of control involving BioRegenx, Inc. for 851,977,296 common shares and 3,800 Series A preferred shares of the Registrant which represented 90.0% of the voting securities of the Registrant (closed 2024-03-08).
“The name of the Registrant was changed to BioRegenx, Inc. Pursuant to the merger, all of the issued and outstanding BioRegenx common and preferred shares were exchanged for 851,977,296 common shares and 3,800 Series A preferred shares of the Registrant which represented 90.0% of the voting securities of the Registrant. Concurrently, holder(s) of the Registrant’s”
Gary Kiss was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
Jody Walker was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
Suzanne Bird was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
Gary Hennerberg was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
Sherri Adams was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
Robert Doran was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
William Resides was appointed as Director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides Robert Doran Sherri Adams Gary Hennerberg Suzanne Bird Jody Walker Gary Kiss”
Gary Hennerberg was appointed as Secretary at BIOREGENX, INC..
“Gary Hennerberg – Secretary”
Sherri Adams was appointed as Chief Operating Officer at BIOREGENX, INC..
“Sherri Adams – Chief Operating Officer”
Robert Doran was appointed as Executive Vice President at BIOREGENX, INC..
“Robert Doran – Executive Vice President”
William Resides was appointed as Interim Financial Officer at BIOREGENX, INC..
“William Resides – Chief Executive Officer, Interim Financial Officer”
William Resides was appointed as Chief Executive Officer at BIOREGENX, INC..
“William Resides – Chief Executive Officer, Interim Financial Officer”
Raymond Firth resigned as director at BIOREGENX, INC..
“Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant”
Thomas Powers resigned as other_named_officer at BIOREGENX, INC..
“Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant”
Raymond Firth resigned as other_named_officer at BIOREGENX, INC..
“Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant”
Sherri Adams resigned as Director at BIOREGENX, INC..
“Effective July 17, 2024, Sherri Adams resigned as an officer and director of the Company to pursue other business interests.”
Sherri Adams resigned as Officer at BIOREGENX, INC..
“Effective July 17, 2024, Sherri Adams resigned as an officer and director of the Company to pursue other business interests.”
Jody M. Walker resigned as director at BIOREGENX, INC..
“In conjunction with her retirement, Jody M. Walker resigned as a director of the Company effective as of July 13, 2024.”
BIOREGENX, INC. dismissed BF Borgers CPA PC as its auditor.
“On May 15, 2024, BioRegenx, Inc. (the “Company”) dismissed BF Borgers CPA PC (“BF Borgers”) as its independent registered public accounting firm.”
BIOREGENX, INC.: Filed Certificate of Designation to cure 2013 creation of Series A preferred shares (effective 2024-03-14).
“Effective March 14, 2024, the Registrant filed a Certificate of Designation (and subsequently, a Certificate of Correction) curing the 2013 creation of the Series A preferred shares and ratifying the issuances of 5,000,000 Series A preferred shares in 2013”
BIOREGENX, INC.: Company name changed to BioRegenx, Inc (effective 2024-03-08).
“Additionally, the name of the Registrant was changed to BioRegenx, Inc.”
BIOREGENX, INC.: Increased authorized common stock to 1.5 billion shares (effective 2024-03-08).
“Effective March 8, 2024, the Registrant filed an Amendment to the Articles of Incorporation which increased the authorized common stock to One Billion Five Hundred Thousand (1,500,000,000) common shares.”
BIOREGENX, INC. underwent a change of control involving BioRegenx, Inc. (closed 2024-03-08).
“The Registrant filed Articles of Merger effective March 8, 2024 with the state of Nevada. Pursuant to the Articles of Merger, BioRegenx, Inc, a Nevada corporation was merged into the Registrant with the Registrant being the surviving company.”
Gary Kiss was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
Jody Walker was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
Suzanne Bird was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
Gary Hennerberg was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
Sherri Adams was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
Robert Doran was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
William Resides was appointed as director at BIOREGENX, INC..
“the following directors were appointed to join Thomas Powers on the Board of Directors: William Resides, Robert Doran, Sherri Adams, Gary Hennerberg, Suzanne Bird, Jody Walker, Gary Kiss”
Gary Hennerberg was appointed as Secretary at BIOREGENX, INC..
“the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary”
Sherri Adams was appointed as Chief Operating Officer at BIOREGENX, INC..
“the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary”
Robert Doran was appointed as Executive Vice President at BIOREGENX, INC..
“the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary”
William Resides was appointed as Chief Executive Officer, Interim Financial Officer at BIOREGENX, INC..
“the following officers were appointed: William Resides – Chief Executive Officer, Interim Financial Officer Robert Doran – Executive Vice President Sherri Adams – Chief Operating Officer Gary Hennerberg – Secretary”
Raymond Firth resigned as director at BIOREGENX, INC..
“Effective March 8, 2024, Raymond Firth resigned as a director of the Registrant”
Thomas Powers resigned as other_named_officer at BIOREGENX, INC..
“Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant”
Raymond Firth resigned as other_named_officer at BIOREGENX, INC..
“Effective March 8, 2024, Raymond Firth and Thomas Powers resigned as officers of the Registrant”
BIOREGENX, INC. entered into Merger Agreement with BioRegenx, Inc. (effective 2022-12-29).
“On December 29, 2022, Findit, Inc. (the “Company” or “Findit”) announced it had entered into a definitive merger agreement (the “Merger Agreement”) with BioRegenx, Inc. (“BioRegenx”), a Nevada corporation.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.